Farms.com Home   News

Agriculture's Grain Sector Look's Promising

Considering all the commodities that are in trouble right now, agriculture is still doing well on the grain sector.
 
Errol Anderson with ProMarket Communications says he'll be watching what happens in the USDA report, especially on canola. 
 
"If the USDA gives us a  bullish nod, the November contract we believe has heavy resistance around $488 a metric tonne. Now, if the USDA does not give us a bullish nod, there's a possibility we could fall down below $470 again. So, we're within a $20 window, it's going to likely stay in that range over the next month and I guess weather will basically tell the story."
 
He says the markets are watching and reacting to the weather globally right now and cited the improvement we've seen in the wheat market as an example. 
 
"It's really because of the production cutbacks in both Europe and in Russia. That's provided us some support it created some short coverings. So, there's evidence right now that the wheat market on the futures Stateside has possibly bottomed, and we're gonna start to firm up."
 
He says the demand market for durum is solid, with bids for Number 1, 13% protein at around $8 or higher adding he wouldn't be surprised to see it go higher post-harvest.
 
Anderson notes wheat, durum, peas, and lentils all look promising especially the pulses post-harvest.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.